Dietary management of nystagmus.
Two case reports illustrate the therapeutic response of congenital nystagmus to a diet eliminating synthetic food colors, synthetic food flavors, the antioxidant preservatives butylated hydroxytoluene (BHT) and butylated hydroxyanisole (BHA), and a small group of foods thought to contain a natural salicylate radical. A brief discussion of the hyperkinetic syndrome is offered with the proposal that a variety of neurologic and neuromuscular disturbances (grand mal, petit mal, psychomotor seizures; La Tourette syndrome; autism; retardation; the behevioral component of Down's syndrome; and oculomotor disturbances) may be induced by identical chemicals, depending upon the individual's genetic profile and the interaction with other environmental factors. It is perhaps the failure to integrate all the signs presented by the various clinical patterns with hyperkinesis or Minimal Brain Dysfunction (MBD) under a single heading that eye muscle involvement manifested as either nystagmus or strabismus has not been emphasized as part of the hyperkinetic syndrome.
D002675:Child, Preschool; D005260:Female; D005503:Food Additives / Q000009:adverse effects*; D005505:Food Coloring Agents / Q000009:adverse effects; D005520:Food Preservatives / Q000009:adverse effects; D006801:Humans; D006948:Hyperkinesis / Q000178:diet therapy* / Q000209:etiology; D007223:Infant; D008297:Male; D009759:Nystagmus, Pathologic / Q000178:diet therapy* / Q000209:etiology; D012459:Salicylates / Q000009:adverse effects*
D005503:Food Additives; D005505:Food Coloring Agents; D005520:Food Preservatives; D012459:Salicylates